THOUSAND
OAKS, Calif., May 26, 2023
/PRNewswire/ -- Amgen (NASDAQ: AMGN) will present at the TD Cowen
4th Annual Oncology Innovation Summit at 11:00 a.m. ET on Wednesday, May 31, 2023.
David M. Reese, M.D., executive vice
president of Research and Development at Amgen will present at the
conference. The webcast will be broadcast over the internet
simultaneously and will be available to members of the news media,
investors and the general public.
The webcast, as with other selected presentations regarding
developments in Amgen's business given by management at certain
investor and medical conferences, can be found on Amgen's website,
www.amgen.com, under Investors. Information regarding presentation
times, webcast availability and webcast links are noted on Amgen's
Investor Relations Events Calendar. The webcast will be archived
and available for replay for at least 90 days after the event.
About Amgen
Amgen is committed to unlocking the potential of biology for
patients suffering from serious illnesses by discovering,
developing, manufacturing and delivering innovative human
therapeutics. This approach begins by using tools like advanced
human genetics to unravel the complexities of disease and
understand the fundamentals of human biology.
Amgen focuses on areas of high unmet medical need and
leverages its expertise to strive for solutions that improve health
outcomes and dramatically improve people's lives. A biotechnology
pioneer since 1980, Amgen has grown to be one
of the world's leading independent biotechnology
companies, has reached millions of patients around the world and is
developing a pipeline of medicines with breakaway
potential.
Amgen is one of the 30 companies that comprise the Dow
Jones Industrial Average and is also part of the Nasdaq-100 index.
In 2022, Amgen was named one of the "World's Best Employers" by
Forbes and one of "America's 100 Most Sustainable Companies" by
Barron's.
For more information, visit Amgen.com and follow us
on Twitter, LinkedIn, Instagram, TikTok and
YouTube.
CONTACT: Amgen, Thousand Oaks
Jessica Akopyan, 805-440-5721
(media)
Arvind Sood, 805-447-1060
(investors)
View original content to download
multimedia:https://www.prnewswire.com/news-releases/amgen-to-present-at-the-td-cowen-4th-annual-oncology-innovation-summit-301835840.html
SOURCE Amgen